Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
!!Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
CSF dynamics as a predictor of cognitive progression
Petrice M. Cogswell
, Stephen D. Weigand
, Heather J. Wiste
, Jeffrey L. Gunter
,
Jonathan Graff-Radford
,
David T. Jones
,
Christopher G. Schwarz
, Matthew L. Senjem
,
David S. Knopman
,
Ronald C. Petersen
,
Clifford R. Jack
Radiology
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CSF dynamics as a predictor of cognitive progression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cognitive Growth
100%
CSF Dynamics
100%
Disproportionately Enlarged Subarachnoid-space Hydrocephalus
100%
Cognitive Decline
36%
Cognitively Unimpaired
27%
Mayo Clinic Study of Aging
18%
Mild Cognitive Impairment
18%
Cortical Thickness
18%
Image Features
18%
Clinical Trials
9%
Cognitive Impairment
9%
Cognitive Dementia
9%
Clinical Significance
9%
Well-defined
9%
Population-based
9%
Community Setting
9%
APOE Genotype
9%
Support Vector Machine
9%
First Diagnosis
9%
3T MRI
9%
Cognitive Testing
9%
Visuospatial
9%
CSF Space
9%
T1-weighted MRI
9%
Cox Proportional Hazards Model
9%
Memory-guided Attention
9%
Cognitive Domains
9%
Intracranial Volume
9%
Linear Mixed Model
9%
Sylvian Fissure
9%
White Matter Hyperintensity Volume
9%
Ventriculomegaly
9%
Indirect Markers
9%
Tight High Convexity
9%
Dynamic Disorder
9%
Machine-based Methods
9%
Imaging Patterns
9%
Domain Memory
9%
Medicine and Dentistry
Cerebrospinal Fluid
100%
Subarachnoid Space
100%
Hydrocephalus
100%
Cognitive Decline
36%
Magnetic Resonance Imaging
18%
Mild Cognitive Impairment
18%
Clinical Trial
9%
Clinical Significance
9%
Cognitive Defect
9%
Proportional Hazards Model
9%
Sylvian Fissure
9%
Ventriculomegaly
9%
Diseases
9%
Education
9%
Neuroscience
Subarachnoid Space
100%
Hydrocephalus
100%
Cognitive Decline
36%
Mild Cognitive Impairment
18%
Magnetic Resonance Imaging
18%
Cortical Thickness
18%
Cognitive Disorders
9%
Support Vector Machine
9%
Biochemistry, Genetics and Molecular Biology
Magnetic Resonance Imaging
100%
Clinical Trial
50%
Genotyping
50%
Support Vector Machine
50%